Related Experiment Video
Updated: Jan 16, 2026

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
Fuchs Endothelial Corneal Dystrophy Associations with Systemic Disease, Lifestyle, and Nutritional Intake
Myriam Böhm1,2,3, Aaron R Kaufman1,2, Francesca Kahale1,2
1Cornea Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
Objective:
To evaluate associations between Fuchs endothelial corneal dystrophy (FECD) and systemic comorbidities, lifestyle factors, and dietary patterns, aiming to identify modifiable risk factors and inform therapeutic strategies.
Design:
Case-control study integrating a cross-sectional survey with a retrospective chart review conducted at a tertiary referral center.
Subjects:
The cohort included 100 individuals from the Cornea Service at Massachusetts Eye and Ear Infirmary: 50 patients with FECD and 50 age- and sex-matched controls within a 10-year range. Four controls were excluded due to protocol adherence.
Methods:
Data collection involved chart reviews and a validated 152-item semiquantitative food frequency questionnaire. Smoking and exercise behaviors were assessed through structured questionnaires. Nutrient intake was adjusted for energy using the residual method. Thus, the energy-adjusted intake estimate is the residual from a regression model in which total energy intake is the independent variable and absolute nutrient intake is the dependent variable. Statistical comparisons included Wilcoxon rank-sum and Fisher exact tests (P < 0.05).
Main Outcome Measures:
Prevalence and statistical significance of systemic comorbidities, lifestyle behaviors, and dietary intake associated with FECD.
Results:
Fuchs endothelial corneal dystrophy was associated with hyperlipidemia (74% vs. 50%, P = 0.023) and atrial fibrillation (26% vs. 8%, P = 0.031). Cumulative tobacco exposure was higher in patients with FECD (11.2 ± 15.1 vs. 6.1 ± 14.1 pack-years, P = 0.017). Patients with FECD had higher caloric intake (1862 ± 673 vs. 1463 ± 584 kcal, P = 0.027), reduced total fat (P = 0.036) and monounsaturated fat (P = 0.024), and increased sodium intake (P = 0.021). Elevated intake of zinc (P = 0.011), manganese (P = 0.043), and selenium (P = 0.007) was also observed.
Conclusions:
Fuchs endothelial corneal dystrophy exhibits significant associations with cardiovascular comorbidities, cumulative tobacco exposure, and specific nutritional factors. The identified associations suggest possible directions for future intervention studies as on cardiovascular management, smoking cessation, and dietary modification. Further studies are warranted to explore mechanistic links and develop preventive and therapeutic strategies.
Financial Disclosures:
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
More Related Videos
12:36A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
Related Concept Videos
Coronary Artery Disease I: Introduction
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Nephrotic Syndrome II : Assessment and Medical Management
Photoreceptors and Visual Pathways
Chronic Kidney Disease II: Clinical Manifestations